• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, December 9, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Government signals end to elective surgery ban

by Myles Hume
April 20, 2020
in Local, News
Reading Time: 4 mins read
A A
The ophthalmic sector believes cataract surgery should be given priority once the elective surgery ban is lifted.

The ophthalmic sector believes cataract surgery should be given priority once the elective surgery ban is lifted.

Share on FacebookShare on Twitter

Cataract surgery could feature in an initial wave of elective procedures that are allowed to recommence as the Federal Government prepares to lift a suspension on non-urgent surgery.

In a decision welcomed by RANZCO this week, Federal Health Minister Mr Greg Hunt revealed elective surgery is likely to resume after it was cancelled on 1 April to free up bed space and resources amid concerns about the strain of coronavirus patients on the healthcare system.

Hunt made the announcement after Australia received 60 million face masks with another 100 million more set to arrive at the end of May. The minster acknowledged the National Cabinet would likely sign off on the proposal when the Prime Minister, premiers and chief ministers meet this week.

Heather Mack, RANZCO president.

During the course of the outbreak, RANZCO supported the government’s decision to halt non-urgent surgery. However, with a sustained flattening of the curve, it is now backing a gradual easing of restrictions to ensure Australians can regain access to sight-saving surgery.

“Many non-urgent eye surgeries have been delayed, which was appropriate at the time,” RANZCO president Associate Professor Heather Mack said.

“But as we now all understand how to work with social distancing, the national stocks of [personal protection equipment (PPE)] are being replenished and we’re working together to flatten the curve, it will soon be appropriate to restart surgery, such as fixing cataracts.”

According to the college, ophthalmologists believe it is important to begin with cataract surgery, the most performed eye procedure in Australia that now has an increasing backlog of patients.

Associate Professor Andrew Chang, a RANZCO board director and head of ophthalmology at the Sydney Eye Hospital, told Insight the college welcomed a “staged approach” to the resumption of elective surgery.

He said eye surgeries were effective and life-changing procedures that had a low risk of cross-transmission of infection. In particular, cataract surgery could be among the first to restart because it is considered a high value and high impact procedure that produces predictable outcomes without draining vital PPE supplies and resources.

Andrew Chang, RANZCO and Sydney Eye Hospital.

“If you consider major surgery, which are aerosol generating procedures and general anaesthesia, then full PPE is needed and this is needed by the surgeons, the nursing staff and the anaesthetist. But cataract surgery is performed under local anaesthetic, the drapes cover the mouth and nose, reducing the risk of cross transmission, which is why cataract surgery may be considered for early lifting of the suspension of elective surgery,” he said.

“We also appreciate that access to PPE has been a real concern for the government and an issue for the medical sector as a whole. The disposable equipment that we use is pre-packaged especially for eye surgery, which include drapes and gowns, and this does not reduce the national stockpile of PPE required for COVID patients.”

Chang added that cataract patients could typically be sent home on the same day after surgery, meaning they would not occupy hospital bed space.

RANZCO has produced its own COVID-19 Triage Guidelines to ensure the safety of patients and ophthalmologists. Chang said eyecare professionals also understood the mandated requirements, which would be observed when any elective surgery recommences.

“Hospitals have made changes to their waiting rooms, staggered patients so they are further apart and have encouraged patients to attend with only one escort, which is helping reduce the number of people entering the facilities,” he said.

Ophthalmologists would also review and update their treatment protocols to minimise the number of face-to-face appointments following surgeries, Chang added.

Australian Society of Ophthalmologists president Dr Peter Sumich said the health sector understood that COVID as a whole could be damaging, “but we don’t want the secondary health impact of delayed procedures to end up being greater than COVID”.

“We are very mindful that everything that’s been deferred or delayed might have an impact – whether it’s a middle aged man with chest tightness that doesn’t go for an angiogram or a person with belly pain who doesn’t have a colonoscopy done, so we are just starting to have that conversation amongst ourselves about when is the right time to go back,” he told RN Breakfast. 

Tags: Andrew ChangcataractcoronavirusCOVID-19COVID-19 Triage Guidelineelective surgeryHeather Macknon-urgent surgeryPPERANZCOSydney Eye Hospital

Related Posts

Actress and entrepreneur Naomi Watts is promoting eye health as part of healthy ageing. Image: Denis Makarenko/shutterstock.com.

Aussie star Watts, J&J team up to promote eye health

by Staff Writer
December 9, 2025

Johnson & Johnson, a global leader in eye health, has partnered with Australian Academy Award–nominated actress, producer, and entrepreneur Ms...

Mr Mark Nevin began his professional life as an
optometrist in Ireland and the UK. Image: Optometry Australia

Optometry Australia announces new CEO

by Staff Writer
December 9, 2025

Optometry Australia (OA) has appointed Mr Mark Nevin as CEO, following the departure of Ms Skye Cappuccio, who was at...

Holly Cafe worked her way through nearly every role on the retail side during her journey to partnership. Image: Holly Cafe.

Owning the vision – pathways to partnership

by Rhiannon Bowman and Rob Mitchell
December 8, 2025

Three dispensing and retail directors tell Insight how they made their way to investing in an optometry practice – sometimes...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited